Thyroid hormone levels in patients with bipolar disorder: a systematic review and meta-analysis

Abstract Purpose To investigate the difference in blood (serum/plasma) thyroid hormone (TH) levels, including thyroid-stimulating hormone (TSH), thyroxine (T4), triiodothyronine (T3), free thyroxine (FT4), and free triiodothyronine (FT3), in bipolar disorder (BD) during different mood episodes (depr...

Full description

Saved in:
Bibliographic Details
Main Authors: Shanshan Liu, Xiaoai Chen, Xiaotao Li, Limin Tian
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Endocrine Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12902-024-01776-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850162727265239040
author Shanshan Liu
Xiaoai Chen
Xiaotao Li
Limin Tian
author_facet Shanshan Liu
Xiaoai Chen
Xiaotao Li
Limin Tian
author_sort Shanshan Liu
collection DOAJ
description Abstract Purpose To investigate the difference in blood (serum/plasma) thyroid hormone (TH) levels, including thyroid-stimulating hormone (TSH), thyroxine (T4), triiodothyronine (T3), free thyroxine (FT4), and free triiodothyronine (FT3), in bipolar disorder (BD) during different mood episodes (depression and mania) compared with healthy control (HC) and between manic episodes (BD-M) and depressive episodes (BD-D). Methods As of September 1, 2024, the electronic databases PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, China Science and Technology Journal Database, Wanfang Database, and Clinical Trials. Gov were systematically searched with no language limitations. Standardized mean differences (SMD) with 95% confidence interval (CI) were summarized using a random effects model. The chi-squared-based Q test and the I 2 test assessed the size of heterogeneity. Results The 21 studies included a total of 3696 participants, Of the 2942 BD patients, 1583 were in depressive episodes 1359 were in manic episodes. The status of measuring blood TH levels included 2 studies in plasma and 19 in serum. Combined with the results of the sensitivity analyses, we obtained the following relatively reliable results: serum T3 (SMD: -0.63, 95%CI: -1.09 to -0.17) and FT3 (SMD: -0.42, 95%CI: -0.83 to -0.00) levels decreased significantly in BD-D compared to HC; serum T3 (SMD: -0.91, 95%CI: -1.49 to -0.32) levels decreased significantly and serum FT4 (SMD: 0.37, 95%CI: 0.14 to 0.60) levels increased significantly in BD-M than in HC; serum T3 (SMD: 0.87, 95%CI: 0.24 to 1.49) and FT3 (SMD: 0.27, 95%CI: 0.13 to 0.42) levels demonstrated a significant elevation in BD-M compared to BD-D. In the group of euthyroidism, apart from serum FT4 (SMD: 0.21, 95%CI: -0.15 to 0.58) levels showed no significant difference between BD-M and HC, other results above remained consistent. Conclusion Serum T3 and FT3 levels decreased significantly in BD-D compared to HC. Serum T3 levels decreased significantly and serum FT4 levels increased significantly in BD-M compared to HC. Serum T3 and FT3 levels increased significantly in BD-M than in BD-D. The temporality of changes in TH levels and BD progression demands further longitudinal studies to illustrate. Trial registration Number and date of registration for prospectively registered trials No. CRD42022378530.
format Article
id doaj-art-bd100799fc02468cbfde3cdbe4e8c5af
institution OA Journals
issn 1472-6823
language English
publishDate 2024-11-01
publisher BMC
record_format Article
series BMC Endocrine Disorders
spelling doaj-art-bd100799fc02468cbfde3cdbe4e8c5af2025-08-20T02:22:29ZengBMCBMC Endocrine Disorders1472-68232024-11-0124111810.1186/s12902-024-01776-1Thyroid hormone levels in patients with bipolar disorder: a systematic review and meta-analysisShanshan Liu0Xiaoai Chen1Xiaotao Li2Limin Tian3The First Clinical Medical College, Gansu University of Chinese MedicineDepartment of Endocrinology, Gansu Provincial HospitalDepartment of Endocrinology, Gansu Provincial HospitalThe First Clinical Medical College, Gansu University of Chinese MedicineAbstract Purpose To investigate the difference in blood (serum/plasma) thyroid hormone (TH) levels, including thyroid-stimulating hormone (TSH), thyroxine (T4), triiodothyronine (T3), free thyroxine (FT4), and free triiodothyronine (FT3), in bipolar disorder (BD) during different mood episodes (depression and mania) compared with healthy control (HC) and between manic episodes (BD-M) and depressive episodes (BD-D). Methods As of September 1, 2024, the electronic databases PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, China Science and Technology Journal Database, Wanfang Database, and Clinical Trials. Gov were systematically searched with no language limitations. Standardized mean differences (SMD) with 95% confidence interval (CI) were summarized using a random effects model. The chi-squared-based Q test and the I 2 test assessed the size of heterogeneity. Results The 21 studies included a total of 3696 participants, Of the 2942 BD patients, 1583 were in depressive episodes 1359 were in manic episodes. The status of measuring blood TH levels included 2 studies in plasma and 19 in serum. Combined with the results of the sensitivity analyses, we obtained the following relatively reliable results: serum T3 (SMD: -0.63, 95%CI: -1.09 to -0.17) and FT3 (SMD: -0.42, 95%CI: -0.83 to -0.00) levels decreased significantly in BD-D compared to HC; serum T3 (SMD: -0.91, 95%CI: -1.49 to -0.32) levels decreased significantly and serum FT4 (SMD: 0.37, 95%CI: 0.14 to 0.60) levels increased significantly in BD-M than in HC; serum T3 (SMD: 0.87, 95%CI: 0.24 to 1.49) and FT3 (SMD: 0.27, 95%CI: 0.13 to 0.42) levels demonstrated a significant elevation in BD-M compared to BD-D. In the group of euthyroidism, apart from serum FT4 (SMD: 0.21, 95%CI: -0.15 to 0.58) levels showed no significant difference between BD-M and HC, other results above remained consistent. Conclusion Serum T3 and FT3 levels decreased significantly in BD-D compared to HC. Serum T3 levels decreased significantly and serum FT4 levels increased significantly in BD-M compared to HC. Serum T3 and FT3 levels increased significantly in BD-M than in BD-D. The temporality of changes in TH levels and BD progression demands further longitudinal studies to illustrate. Trial registration Number and date of registration for prospectively registered trials No. CRD42022378530.https://doi.org/10.1186/s12902-024-01776-1Bipolar disorderDepressionManiaThyroid hormoneMeta-analysis
spellingShingle Shanshan Liu
Xiaoai Chen
Xiaotao Li
Limin Tian
Thyroid hormone levels in patients with bipolar disorder: a systematic review and meta-analysis
BMC Endocrine Disorders
Bipolar disorder
Depression
Mania
Thyroid hormone
Meta-analysis
title Thyroid hormone levels in patients with bipolar disorder: a systematic review and meta-analysis
title_full Thyroid hormone levels in patients with bipolar disorder: a systematic review and meta-analysis
title_fullStr Thyroid hormone levels in patients with bipolar disorder: a systematic review and meta-analysis
title_full_unstemmed Thyroid hormone levels in patients with bipolar disorder: a systematic review and meta-analysis
title_short Thyroid hormone levels in patients with bipolar disorder: a systematic review and meta-analysis
title_sort thyroid hormone levels in patients with bipolar disorder a systematic review and meta analysis
topic Bipolar disorder
Depression
Mania
Thyroid hormone
Meta-analysis
url https://doi.org/10.1186/s12902-024-01776-1
work_keys_str_mv AT shanshanliu thyroidhormonelevelsinpatientswithbipolardisorderasystematicreviewandmetaanalysis
AT xiaoaichen thyroidhormonelevelsinpatientswithbipolardisorderasystematicreviewandmetaanalysis
AT xiaotaoli thyroidhormonelevelsinpatientswithbipolardisorderasystematicreviewandmetaanalysis
AT limintian thyroidhormonelevelsinpatientswithbipolardisorderasystematicreviewandmetaanalysis